Category : Research & Tools

MyNewGut is a European gut microbiome research initiative launched in 2013 that brings together experts in a wide range of fields: 'omics' technologies, brain research, computational modelling, immunology, microbiology, physiology and nutrition. The endeavour includes both basic research and clinical trials, with the aim of producing high-quality data that can inform medical practice and public health initiatives around the world.…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

MyNewGut is a European gut microbiome research initiative launched in 2013 that brings together experts in a wide range of fields: 'omics' technologies, brain research, computational modelling, immunology, microbiology, physiology and nutrition. The endeavour includes both basic research and clinical trials, with the aim of producing high-quality data that can inform medical practice and public health initiatives around the world.…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

A major limitation of current methods of gut microbiota analysis (16S rRNA amplicon sequencing and metagenomics) is that preparing the bacterial DNA for sequencing destroys the fine spatial organization of the sample. Researchers have limited tools for 3-dimensional visualization of the anaerobic commensal bacteria in a living host. Geva-Zatorsky, et al. recently reported that they used metabolic oligosaccharide engineering and…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

A major limitation of current methods of gut microbiota analysis (16S rRNA amplicon sequencing and metagenomics) is that preparing the bacterial DNA for sequencing destroys the fine spatial organization of the sample. Researchers have limited tools for 3-dimensional visualization of the anaerobic commensal bacteria in a living host. Geva-Zatorsky, et al. recently reported that they used metabolic oligosaccharide engineering and…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

As MyNewGut, a research initiative involving thirty organizations from fifteen countries, continued to carry out its research program on prebiotic fibres and the gut microbiota, project participants held a workshop before the International Dietary Fibre Conference 2015 in Paris. With presentations by well-known researchers, as well as industry and government representatives, the workshop brought together plans for updating and implementing…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

As MyNewGut, a research initiative involving thirty organizations from fifteen countries, continued to carry out its research program on prebiotic fibres and the gut microbiota, project participants held a workshop before the International Dietary Fibre Conference 2015 in Paris. With presentations by well-known researchers, as well as industry and government representatives, the workshop brought together plans for updating and implementing…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

For Dr. Vanni Bucci, assistant professor of computational biology at the University of Massachusetts Dartmouth, new treatments are not the only way to make progress in medicine. He believes doctors can greatly improve care by making better use of treatments that already exist -- even common ones like antibiotics. Bucci, a chemical/environmental engineer by training, builds mathematical models to describe…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

For Dr. Vanni Bucci, assistant professor of computational biology at the University of Massachusetts Dartmouth, new treatments are not the only way to make progress in medicine. He believes doctors can greatly improve care by making better use of treatments that already exist -- even common ones like antibiotics. Bucci, a chemical/environmental engineer by training, builds mathematical models to describe…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Ramy K. Aziz is an Assistant Professor of Microbiology and Immunology in the Faculty of Pharmacy at Cairo University. He was previously a visiting scientist at UC San Diego, USA. Dr. Aziz's research focuses on microbial pathogenesis, genomics, and macrobiomics; he is particularly interested in systems biology perspectives. Dr. Aziz gave a talk at Experimental Biology 2015 called, "Pharmacomicrobiomics:…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Ramy K. Aziz is an Assistant Professor of Microbiology and Immunology in the Faculty of Pharmacy at Cairo University. He was previously a visiting scientist at UC San Diego, USA. Dr. Aziz's research focuses on microbial pathogenesis, genomics, and macrobiomics; he is particularly interested in systems biology perspectives. Dr. Aziz gave a talk at Experimental Biology 2015 called, "Pharmacomicrobiomics:…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Thousands of years ago, humans went beyond hunting and gathering and began purposefully selecting and growing the most beneficial plants; what we know as the agricultural revolution was born. Is it possible that cultivating the microbiome would create a comparable paradigm shift? The idea of consuming probiotics has received a lot of attention. Probiotics are not necessarily selected over numerous…

GMFH Editing Team
GMFH Editing Team

Thousands of years ago, humans went beyond hunting and gathering and began purposefully selecting and growing the most beneficial plants; what we know as the agricultural revolution was born. Is it possible that cultivating the microbiome would create a comparable paradigm shift? The idea of consuming probiotics has received a lot of attention. Probiotics are not necessarily selected over numerous…

GMFH Editing Team
GMFH Editing Team

The Third International Congress of Translational Research in Human Nutrition (#ICTRHN2015) took place in Clermont-Ferrand, France, on June 26 & 27, 2015.     In this post, we bring you the highlights of the event introduction on microbiota-host crosstalk and of the first two symposia: new approaches in microbiota characterization, and gut inflammation. Introductory lecture - Microbiota-host crosstalks: Decrypting signals in…

Amandine Everard
Postdoctoral position, supported by the FNRS (Fond National de la Recherche Scientifique), in the metabolism and nutrition research group (team of Prof. Patrice D. Cani), at the Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL). CERTIFICATE : Master in Pharmaceutical Sciences, Université catholique de Louvain (UCL), 2010 - Doctoral in Biomedical and Pharmaceutical Sciences supervised by the Professor Patrice D. Cani, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), 2014. RESEARCH INTERESTS: Interactions between gut microbiota and intestinal epithelium in metabolic disorders associated with obesity.

The Third International Congress of Translational Research in Human Nutrition (#ICTRHN2015) took place in Clermont-Ferrand, France, on June 26 & 27, 2015.     In this post, we bring you the highlights of the event introduction on microbiota-host crosstalk and of the first two symposia: new approaches in microbiota characterization, and gut inflammation. Introductory lecture - Microbiota-host crosstalks: Decrypting signals in…

Amandine Everard
Postdoctoral position, supported by the FNRS (Fond National de la Recherche Scientifique), in the metabolism and nutrition research group (team of Prof. Patrice D. Cani), at the Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL). CERTIFICATE : Master in Pharmaceutical Sciences, Université catholique de Louvain (UCL), 2010 - Doctoral in Biomedical and Pharmaceutical Sciences supervised by the Professor Patrice D. Cani, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), 2014. RESEARCH INTERESTS: Interactions between gut microbiota and intestinal epithelium in metabolic disorders associated with obesity.

Do specific microbiota determine levels of specific metabolites? How does the metabolite profile develop during establishment of the microbiome in infants? Can we assess an individual’s physiological state based on gut flora and metabolites? These questions are key to translating scientific findings related to intestinal metabolites in order to bring them to the clinic. The relatively new scientific field of…

Stefan Jellbauer
Stefan Jellbauer is a Field Application Scientist in the Biotech industry. Previously, he was an ORISE fellow at the Food Safety division of the FDA and a Postdoc in Manuela Raffatellu’s lab at University of California, Irvine, where he studied host-pathogen interactions and mucosal immunology. He obtained his PhD in 2010 from Ludwig-Maximilians University in Munich, Germany.

Do specific microbiota determine levels of specific metabolites? How does the metabolite profile develop during establishment of the microbiome in infants? Can we assess an individual’s physiological state based on gut flora and metabolites? These questions are key to translating scientific findings related to intestinal metabolites in order to bring them to the clinic. The relatively new scientific field of…

Stefan Jellbauer
Stefan Jellbauer is a Field Application Scientist in the Biotech industry. Previously, he was an ORISE fellow at the Food Safety division of the FDA and a Postdoc in Manuela Raffatellu’s lab at University of California, Irvine, where he studied host-pathogen interactions and mucosal immunology. He obtained his PhD in 2010 from Ludwig-Maximilians University in Munich, Germany.

Dysbiosis -- an abnormal gut microbiota -- is associated with several diseases, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Yet because of the great variation in gut microbiota composition between individuals, dysbiosis can be difficult to define. In a recent article published in Alimentary Pharmacology and Therapeutics, researchers introduce a new diagnostic test that they say can…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Dysbiosis -- an abnormal gut microbiota -- is associated with several diseases, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Yet because of the great variation in gut microbiota composition between individuals, dysbiosis can be difficult to define. In a recent article published in Alimentary Pharmacology and Therapeutics, researchers introduce a new diagnostic test that they say can…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

The Gut Microbiota for Health meeting (Barcelona, Spain, March 13-15) particularly emphasized the applications of gut microbiota science. Scientists haven’t yet identified the ‘healthiest’ microbial composition, but what’s clear so far is that a diverse colonizing microbiota is important: more diversity means greater resilience, with the potential to make you generally healthier and able to resist specific diseases. With input…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

The Gut Microbiota for Health meeting (Barcelona, Spain, March 13-15) particularly emphasized the applications of gut microbiota science. Scientists haven’t yet identified the ‘healthiest’ microbial composition, but what’s clear so far is that a diverse colonizing microbiota is important: more diversity means greater resilience, with the potential to make you generally healthier and able to resist specific diseases. With input…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).